Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 5.238.608.177.076.05

What is the latest Working Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Working Capital/Sales ratio of PIRAMAL PHARMA is 5.23 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20255.23
Mar20248.60
Mar20238.17
Mar20227.07
Mar20216.05

How is Working Capital/Sales of PIRAMAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 5.23
-39.19
Mar2024 8.6
5.26
Mar2023 8.17
15.56
Mar2022 7.07
16.86
Mar2021 6.05 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Working Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹23,540.1 Cr 6.4% -4.2% -29.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,884.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹172,442.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,770.0 Cr 1.3% 2.7% 10% Stock Analytics
CIPLA ₹120,871.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,693.0 Cr -1% 2.5% -4.4% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

6.4%

-4.2%

-29.6%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses